CRP and sarcopenia: Frailty exacerbates this process, as inflammatory markers such as IL-6 and C-reactive protein (CRP) further stimulate the RAAS, creating a cycle where RAAS-mediated inflammation worsens sarcopenia and frailty-related metabolic dysfunction amplifies cardiovascular damage.